Pfizer (PFE) Buildings (2009 - 2013)

Pfizer (PFE) has reported Buildings for 5 consecutive years, with $10.1 billion the latest figure, recorded in Q4 2013.

• On a quarterly basis, Buildings fell 5.52% year-over-year to $10.1 billion in Q4 2013; TTM through Dec 2013 was $10.1 billion, a 5.52% decrease from a year earlier, with the FY2013 full-year figure at $10.1 billion, down 5.52% from the prior year.
• Buildings was $10.1 billion for Q4 2013 at Pfizer, down from $10.6 billion in the prior quarter.
• Over five years, Buildings peaked at $14.2 billion in Q4 2009 and troughed at $10.1 billion in Q4 2013.
• A 5-year average of $12.0 billion and a median of $12.1 billion in 2011 frame the typical range for Buildings.
• Across the five-year window, Buildings declined 11.96% in 2012 and fell 5.52% in 2013, its largest moves.
• Over 5 years, Buildings stood at $14.2 billion in 2009, then declined by 6.95% to $13.2 billion in 2010, then decreased by 8.42% to $12.1 billion in 2011, then decreased by 11.96% to $10.6 billion in 2012, then dropped by 5.52% to $10.1 billion in 2013.
• The last three Buildings figures came in at $10.1 billion (Q4 2013), $10.6 billion (Q4 2012), and $12.1 billion (Q4 2011), per Business Quant data.